signs reseller and integration agreement with Biosign


TORONTO, Dec. 11 /CNW/ - Biosign Technologies Inc. (CNSX: BIO) ("Biosign" or the "Company") and announced today they have entered into an alliance agreement that enables to resell Biosign products and integrate patient driven data into the Personal Health Record (PHR) treatment management service.

Biosign and will integrate their platforms for the recording and retrieval of in-office and remote patient vital sign measurements through the PHR.

The first products to be integrated into the PHR will consist of Biosign's blood pressure and hemodynamic monitors (UFIT(R) TEN-10) including automated reading, scheduling, result verification, tracking, charting and trending.

Alan Paget, CTO of states, "We work closely with clinicians and researchers to ensure that our suite of services assist in providing the best possible care for patients and can help improve effectiveness of treatment. Linking the UFIT(R) quality data from in-office encounters, ambulatory protocols, and remotely monitored patients into PHR is an invaluable meaningful use solution that will help facilitate proactive treatment of patients."

"We are continuing with our strategy of partnering with key EMR and PHR vendors to enable the availability of integrated solutions for patient management. We believe that the HealthSaaS' innovative suite of patient care services, their robust PHR, and our UFIT(R) platform collectively create an end-to-end solution for better patient care in the U.S marketplace," remarked John Anders, Vice President of Business Development for Biosign.

About Biosign Technologies Inc.

Biosign provides biomedical systems. Key applications include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT(R) medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring.


The PHR is a web based Software as a Service (SaaS) application that enables patients to record multi-conditions/multi-doctors, pain locations, pain types, pain intensity, medications, naturopathic remedies, sleep patterns, treatments, therapies, exercise, activities, additional symptoms, and quality of life concerns.

The PHR facilitates better communication between patients and their healthcare providers through account file sharing or secure Provider Portals. Patient driven report data will help providers identify both effective and ineffective treatments and medications. Healthcare providers may then make treatment and medication modifications to improve efficacy and provide patient-members with a more consistent and improved quality of life. also offers fee based services to support clinical trials and research studies. Fee based analytic services are available to help clinicians, researchers, pharmaceutical companies, and payors improve efficiencies.

The CNSX has neither approved nor disapproved the contents of this press release.

%SEDAR: 00014068E

SOURCE Biosign Technologies Inc.

For further information: For further information: Contact Information for Biosign Technologies: John T. Anders, Vice-President, Business Development, Biosign Technologies Inc., Phone: (416) 218-9800 ext. 237, Email:; Contact Information for Alan Paget, Chief Technology Officer,, Phone: (503) 882-8951, E-mail:

Organization Profile

Biosign Technologies Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890